Quantitative coronary plaque characteristics on coronary computed tomography angiography and their prognostic value in patients with chronic kidney disease.
- 1Department of Radiology, Fuwai Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, State Key Lab and National Center for Cardiovascular Diseases, Beijing, China.
- 2Department of Structural Heart Disease, Fuwai Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China.
- 3Department of Nephrology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Abstract
Chronic kidney disease (CKD) is associated with an increased risk of cardiovascular events. This study compared coronary plaque characteristics assessed by coronary computed tomography angiography (CCTA) between patients with and without CKD and evaluated their associations with major adverse cardiovascular events (MACE). This secondary analysis of the multicenter CREATION-CHINA cohort included patients with suspected coronary artery disease who underwent CCTA during 2016-2020. CKD was defined as an estimated glomerular filtration rate <60 mL/min/1.73 m2. Propensity score matching (1:3) used age, sex, hypertension, diabetes mellitus, smoking, family history of coronary artery disease, and hyperlipidemia. Quantitative plaque characteristics and perivascular fat attenuation index (FAI) were assessed. MACE comprised all-cause death, non-fatal myocardial infarction, stroke, or revascularization >90 days after CCTA. Cox models estimated hazard ratios (HRs) and 95% confidence intervals (CIs); analyses of CCTA-derived predictors were adjusted for age, body mass index, and hypertension. High plaque burden was defined as total plaque burden in the highest quartile. After matching, 2,267 patients were included (588 with CKD and 1,679 without CKD). During a median follow-up of 3.47 years (interquartile range, 2.36-4.10), MACE occurred in 30 patients with CKD (5.1%) and 52 without CKD (3.1%; P=0.035). Patients with CKD had higher median total plaque volume (39.90 vs. 0 mm3), median total plaque burden (8.83% vs. 0%), and prevalence of high-risk plaque (9.35% vs. 4.35%; all P<0.001). Among patients with CKD, lipid plaque burden (adjusted HR =1.107, 95% CI: 1.006-1.218; P=0.038) and high FAI (adjusted HR =4.027, 95% CI: 2.329-6.960; P<0.001) were independently associated with MACE. Compared with patients without CKD and with low plaque burden, those with CKD and high plaque burden had a higher risk of MACE (adjusted HR =6.153, 95% CI: 2.937-12.890; P<0.001). CKD was associated with greater coronary plaque burden and a higher incidence of MACE. Lipid plaque burden and high FAI were independently associated with MACE after adjustment for age, body mass index, and hypertension, supporting their potential role in cardiovascular risk assessment in patients with CKD.
Related
- Quantification of plaque and detection of high-risk plaque characteristics based on coronary computed tomography angiography: comparison between superresolution deep learning reconstruction and hybrid iterative reconstruction
- Residual Cardiovascular Risk Beyond Coronary Physiology: Complementary Prognostic Value of Trimethylamine N‐Oxide in Patients Undergoing Coronary Computed Tomography Angiography With Computed Tomography‐Derived Fractional Flow Reserve
- Comprehensive coronary computed tomography angiography assessment in high-altitude diabetic populations: integrating plaque characteristics, pericoronary inflammation, and coronary function
- From coronary computed tomography angiography to the cath lab: computed tomography-guided percutaneous coronary intervention of a high-risk left anterior descending artery lesion
- Nonlinear and Vessel-Specific Association Between Coronary Artery Calcium Burden and Coronary Computed Tomography Angiography Underestimation of Coronary Stenosis
BibTeX
@article{yuan2026quantitative,
title = {{Quantitative coronary plaque characteristics on coronary computed tomography angiography and their prognostic value in patients with chronic kidney disease.}},
author = {Ning-Lang Yuan and Wen-Hao Zhu and Wei-Hua Yin and Rui Zhu and Yun-Qiang An and Zhi-Hui Hou and Bin Lu},
journal = {Quantitative imaging in medicine and surgery},
year = {2026},
month = oct,
doi = {10.21037/qims-2026-1-0396},
url = {https://europepmc.org/article/MED/42997945},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Quantitative coronary plaque characteristics on coronary computed tomography angiography and their prognostic value in patients with chronic kidney disease.
AU - Ning-Lang Yuan
AU - Wen-Hao Zhu
AU - Wei-Hua Yin
AU - Rui Zhu
AU - Yun-Qiang An
AU - Zhi-Hui Hou
AU - Bin Lu
PY - 2026
DA - 2026/10/21
JO - Quantitative imaging in medicine and surgery
DO - 10.21037/qims-2026-1-0396
UR - https://europepmc.org/article/MED/42997945
AB - Chronic kidney disease (CKD) is associated with an increased risk of cardiovascular events. This study compared coronary plaque characteristics assessed by coronary computed tomography angiography (CCTA) between patients with and without CKD and evaluated their associations with major adverse cardiovascular events (MACE). This secondary analysis of the multicenter CREATION-CHINA cohort included patients with suspected coronary artery disease who underwent CCTA during 2016-2020. CKD was defined as an estimated glomerular filtration rate <60 mL/min/1.73 m2. Propensity score matching (1:3) used age, sex, hypertension, diabetes mellitus, smoking, family history of coronary artery disease, and hyperlipidemia. Quantitative plaque characteristics and perivascular fat attenuation index (FAI) were assessed. MACE comprised all-cause death, non-fatal myocardial infarction, stroke, or revascularization >90 days after CCTA. Cox models estimated hazard ratios (HRs) and 95% confidence intervals (CIs); analyses of CCTA-derived predictors were adjusted for age, body mass index, and hypertension. High plaque burden was defined as total plaque burden in the highest quartile. After matching, 2,267 patients were included (588 with CKD and 1,679 without CKD). During a median follow-up of 3.47 years (interquartile range, 2.36-4.10), MACE occurred in 30 patients with CKD (5.1%) and 52 without CKD (3.1%; P=0.035). Patients with CKD had higher median total plaque volume (39.90 vs. 0 mm3), median total plaque burden (8.83% vs. 0%), and prevalence of high-risk plaque (9.35% vs. 4.35%; all P<0.001). Among patients with CKD, lipid plaque burden (adjusted HR =1.107, 95% CI: 1.006-1.218; P=0.038) and high FAI (adjusted HR =4.027, 95% CI: 2.329-6.960; P<0.001) were independently associated with MACE. Compared with patients without CKD and with low plaque burden, those with CKD and high plaque burden had a higher risk of MACE (adjusted HR =6.153, 95% CI: 2.937-12.890; P<0.001). CKD was associated with greater coronary plaque burden and a higher incidence of MACE. Lipid plaque burden and high FAI were independently associated with MACE after adjustment for age, body mass index, and hypertension, supporting their potential role in cardiovascular risk assessment in patients with CKD.
SN - 2223-4292
SN - 2223-4306
ER -